Skip to content

Clinical trials

Phase 2 Asthma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 2 Country / region: Japan Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20112
20124
20132
20152
20191
20201
20211
20222
20233
20245
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated5
Active, not recruiting4
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Sanofi6
GlaxoSmithKline5
AstraZeneca4
MedImmune LLC2
Upstream Bio Inc.2
Amgen1
Eli Lilly and Company1
Incyte Corporation1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma30
Lung Diseases3
Respiratory Tract Diseases3
Bronchial Diseases2
Airway Obstruction1
Dyspnea1
Pulmonary Disease, Chronic Obstructive1
Pulmonary Eosinophilia1
Respiratory Hypersensitivity1
Respiratory Sounds1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.